<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName journalpublishing.dtd?>
  <?SourceDTD.Version 2.3?>
  <?ConverterInfo.XSLTName jp2nlmx2.xsl?>
  <?ConverterInfo.Version 2?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Res Med Sci</journal-id>
      <journal-id journal-id-type="publisher-id">JRMS</journal-id>
      <journal-title-group>
        <journal-title>Journal of Research in Medical Sciences : The Official Journal of Isfahan University of Medical Sciences</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1735-1995</issn>
      <issn pub-type="epub">1735-7136</issn>
      <publisher>
        <publisher-name>Medknow Publications Pvt Ltd</publisher-name>
        <publisher-loc>India</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">3129104</article-id>
      <article-id pub-id-type="publisher-id">JRMS-14-327</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Pure ovarian choriocarcinoma: report of two cases</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Mood</surname>
            <given-names>Narges Izadi</given-names>
          </name>
          <xref ref-type="corresp" rid="cor1">*</xref>
          <xref ref-type="aff" rid="aff1">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Samadi</surname>
            <given-names>Nasrin</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rahimi-Moghaddam</surname>
            <given-names>Parvaneh</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sarmadi</surname>
            <given-names>Soheila</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Eftekhar</surname>
            <given-names>Zahra</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">c</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yarandi</surname>
            <given-names>Fariba</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">c</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>a</label>Department of Pathology, Mirza Koochak Khan Hospital, Tehran University of Medical Sciences, Tehran, Iran.</aff>
      <aff id="aff2"><label>b</label>Razi Institute for Drug Research, Iran University of Medical Sciences, Tehran, Iran.</aff>
      <aff id="aff3"><label>c</label>Division of Oncology, Department of Obstetrics and Gynecology, Mirza Koochak Khan Hospital, Tehran University of Medical Sciences, Tehran, Iran.</aff>
      <author-notes>
        <corresp id="cor1"><label>*</label>Corresponding Author E-mail: <email xlink:href="nizadimood@yahoo.com">nizadimood@yahoo.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Sep-Oct</season>
        <year>2009</year>
      </pub-date>
      <volume>14</volume>
      <issue>5</issue>
      <fpage>327</fpage>
      <lpage>330</lpage>
      <history>
        <date date-type="received">
          <day>12</day>
          <month>10</month>
          <year>2008</year>
        </date>
        <date date-type="accepted">
          <day>22</day>
          <month>12</month>
          <year>2008</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Journal of Research in Medical Sciences</copyright-statement>
        <copyright-year>2009</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Pure primary ovarian choriocarcinoma is an extremely rare condition of gestational or nongestational origin. The possibility of gestational origin can be suspected by the presence of a corpus luteum of pregnancy but definite diagnosis would be based on genetic analysis. Here, we present two cases of pure ovarian choriocarcinoma in the forth decade of life with the possibility of gestational origin.</p>
      </abstract>
      <kwd-group>
        <kwd>Gestational</kwd>
        <kwd>Choriocarcinoma</kwd>
        <kwd>Ovary</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>Germ cell malignancies may represent up to 15% of ovarian cancers in Asian and African-American nations, where epithelial ovarian cancers occur less commonly.<xref ref-type="bibr" rid="ref1">1</xref></p>
    <p>Pure ovarian choriocarcinoma is extremely rare, with about 40 cases described in the English language articles.<xref ref-type="bibr" rid="ref2">2</xref> Choriocarcinoma may be gestational or nongestational. The gestational type arises from an ovarian pregnancy or is of metastatic origin from uterine choriocarcinoma, whereas the nongestational type is an extremely rare germ cell neoplasm. To distinguish pure nongestational choriocarcinoma of the ovary from metastatic or primary gestational choriocarcinoma, DNA polymorphism analysis is a useful method.<xref ref-type="bibr" rid="ref3">3</xref><xref ref-type="bibr" rid="ref4">4</xref> The gestational variants are extremely sensitive to chemotherapy with overall cure rate approaching 98% in specialized centers.<xref ref-type="bibr" rid="ref5">5</xref> The prognosis correlates with the bulk of tumor as well as the sites and number of metastases.<xref ref-type="bibr" rid="ref6">6</xref> We present two cases of pure ovarian choriocarcinoma with possibility of gestational origin.</p>
    <sec sec-type="cases" id="sec1-1">
      <title>Case Report</title>
      <p><bold>Case 1:</bold> A 31-year-old woman, with a gestational history of G9, P1, Ab8 and L1 was admitted to Mirza Koochak Khan Hospital, Tehran, Iran in June 2001 with the symptoms and signs of acute abdomen. She had 5 years secondary infertility of unknown reason following her last abortion and gave the history of a missed menstrual period as well as 50 days of spotting. The serum &#x3B2;-hCG level was more than 1000 mIU/ml. Pelvic sonography revealed enlarged right ovary and a 2.7 cm left ovarian cyst. No abnormal finding was detected in uterus. In view of an adnexal mass along with positive pregnancy test, a possibility of ectopic pregnancy was considered. A right salpingo-oophorectomy was carried out. Gross examination of right ovary revealed a 7&#xD7;7&#xD7;4.5 cm<sup>3</sup> mass with a hemorrhagic cut surface. Following thorough sampling of the ovarian mass (1 section per cm of the greatest dimension of the tumor), microscopic examination revealed characteristic histological features of choriocarcinoma, composed of bilami-nar structures of cytotrophoblasts and syncyti-otrophoblasts with severe nuclear atypia and mitotic figures admixed with necrotic tissue. A corpus luteum of pregnancy (<xref ref-type="fig" rid="F1">Figure 1</xref>) with multiple colloid bodies and calcifications was also observed (Figures <xref ref-type="fig" rid="F2">2</xref> and <xref ref-type="fig" rid="F3">3</xref>).The patient received Etoposide/ Metotrexate / Actinomycin D/ Cisplatin/ Etoposide (EMA-CE) regimen for treatment and serum &#x3B2;-hCG level decreased to 70 mIU/mL. She underwent second laparotomy for careful examination of tumoral involvement. Specimens from left ovary and omentum revealed no histologic features of malignancy. A corpus luteum cyst was detected in the left ovary. Computed tomographic scan revealed no brain or lung metastases. Serum alpha- fetoprotein (AFP) was in normal range. After the surgery, she took 4 courses of chemotherapy with EMA-CE regimen. The level of &#x3B2;-hCG decreased to below the cut-off value. There has been no evidence of tumor recurrence during seven years follow-up.</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Corpus luteum of pregnancy adjacent to the tumor (40 x)</p>
        </caption>
        <graphic xlink:href="JRMS-14-327-g001"/>
      </fig>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Calcifications in the corpus luteum of pregnancy (40 x)</p>
        </caption>
        <graphic xlink:href="JRMS-14-327-g002"/>
      </fig>
      <fig id="F3" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Hyaline droplets in the corpus luteum of pregnancy (400 x)</p>
        </caption>
        <graphic xlink:href="JRMS-14-327-g003"/>
      </fig>
      <p><bold>Case 2:</bold> A 32-year-old woman with a gestational history of G3, P2, Ab1 and L2 was admitted to Mirza Koochak Khan Hospital, Tehran, Iran in September 2003 with nausea, vomiting and vaginal spotting. Sonography revealed a large necrotic mass in the left adnexa. Serum &#x3B2;-hCG level was 5500 mIU/mL and AFP level was within the normal range. A large necrotic mass in left ovary with extension to the posterior aspect of uterus was identified in laparotomy. Total abdominal hysterectomy and bilateral salpingo-oophorectomy, tumor debulkation and infracolic omentectomy were performed. On gross examination, there was a left ovarian mass measuring 13&#xD7;11&#xD7;10 cm<sup>3</sup> with lobulated and hemorrhagic-necrotic cut surface. Microscopic examination of the tumor demonstrated clusters of atypical cytotrophoblasts and syncytiotrophoblasts with mitotic figures (<xref ref-type="fig" rid="F4">Figure 4</xref>) as well as a corpus luteum of pregnancy. There was no evidence of other germ cell tumors in multiple provided sections. The tumor was attached to the posterior surface of uterus. However, only serosal lining showed tumor extension. No tumoral involvement was identified in endomyometrium. Computed tomography of chest, abdomen and brain showed no abnormal findings. Since the initial impression of the clinician was more in favor of nongestational choriocarcinoma, the patient at first received 3 courses of Bleomycin/ Etoposide/ Platinum (BEP) regimen for 3 months. Due to incomplete response, the chemotherapy regimen was switched to EMA-CE. After 4 courses of new treatment, the serum &#x3B2;-hCG level reached to less than 5 mIU/mL. No recurrence has been identified during five years follow-up.</p>
      <fig id="F4" position="float">
        <label>Figure 4</label>
        <caption>
          <p>Typical admixture of bilaminar structure of cytotrophoblasts and syncytiotrophoblasts (40 x)</p>
        </caption>
        <graphic xlink:href="JRMS-14-327-g004"/>
      </fig>
    </sec>
    <sec sec-type="discussion" id="sec1-2">
      <title>Discussion</title>
      <p>Choriocarcinoma of the ovary is a rare and aggressive tumor arising from germ cells, constituting less than 5% of all ovarian malignancies in Western countries.<xref ref-type="bibr" rid="ref1">1</xref> Ovarian choriocarcinoma can be divided into three groups: as a metastatic gestational choriocarcinoma due to a regressed or occult primary gestational choriocarcinoma in other parts of the genital tract (mostly uterine corpus); as a primary gestational choriocarcinoma arising from an ectopic ovarian pregnancy, and as a non-gestational germ cell tumor differentiating to trophoblastic components.<xref ref-type="bibr" rid="ref2">2</xref> All types secret &#x3B2;-hCG. However, &#x3B2;-hCG levels are usually lower in nongestational variants in comparison to gestational types.<xref ref-type="bibr" rid="ref7">7</xref> Monitoring of serum &#x3B2;-hCG can be useful method in evaluating response to therapy. Serum &#x3B2;-hCG elevation leads to isosexsual pseudopuberty in premenarchal patients, while patients in reproductive age usually present with menstrual abnormalities (mainly amenorrhea).<xref ref-type="bibr" rid="ref1">1</xref> Pure nongestational ovarian choriocarcinomas are extremely rare and highly malignant tumors frequently metastasizing through the lymphatics with intra-abdominal spread.<xref ref-type="bibr" rid="ref8">8</xref><xref ref-type="bibr" rid="ref9">9</xref> Non-gestational type choriocarcinoma involves the patients with average age of 13 and is largely confined to females under 20. The presence of a well developed corpus luteum of pregnancy adjacent to the tumor may be indicative of a gestational origin.<xref ref-type="bibr" rid="ref8">8</xref> However, a search for paternal DNA in tumor allows a definite distinction between gestational and nongestational types. Tumors with gestational origin have paternal genomic structure while nongestational tumors have genomes of only maternal origin without any alleles from paternal origin.<xref ref-type="bibr" rid="ref2">2</xref> Since DNA polymorphism analysis is not a generally available laboratory technique, we couldn't perform it on our cases.</p>
      <p>Gestational ovarian choriocarcinomas have a better prognosis than their nongestational counterparts.<xref ref-type="bibr" rid="ref10">10</xref><xref ref-type="bibr" rid="ref11">11</xref> However some studies suggest that surgical stage of pure ovarian choriocarcinoma may be more important determinant of clinical outcome compared to being of gestational or nongestational type.<xref ref-type="bibr" rid="ref12">12</xref></p>
      <p>The two presented patients were in the forth decade of life and showed no elements of other germ cell tumors but well developed corpus luteum of pregnancy with hyaline globules and calcifications adjacent to tumor. This finding is in favor of the gestational origin of the tumors. However the possibility of pronounced corpus luteum due to high levels of &#x3B2;-hCG cannot be excluded.</p>
    </sec>
    <sec id="sec1-3">
      <title>Authors&#x2019; Contributions</title>
      <p>NIM carried out the design, histological diagnosis and writing of manuscript. SS did the histological diagnosis and writing of manuscript. NS and PRM wrote and edited the manuscript. ZE and FY did the clinical diagnosis, treatment and follow-up of patients. All authors have read and approved the content of the manuscript.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p>
          <bold>Conflict of Interests</bold>
        </p>
        <p>Authors have no conflict of interests.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="ref1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Corakci</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ozeren</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ozkan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gurbuz</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ustun</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yucesoy</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Pure nongestational choriocarcinoma of ovary</article-title>
          <source>Arch Gynecol Obstet</source>
          <year>2005</year>
          <volume>271</volume>
          <issue>2</issue>
          <fpage>176</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">14991382</pub-id>
        </element-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koo</surname>
              <given-names>HL</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>KR</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
          <article-title>Pure non-gestational choriocarcinoma of the ovary diagnosed by DNA polymorphism analysis</article-title>
          <source>Pathol Int</source>
          <year>2006</year>
          <volume>56</volume>
          <issue>1</issue>
          <fpage>613</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">16984618</pub-id>
        </element-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamamoto</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ino</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sumigama</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nawa</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nomura</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A pure nongestational choriocarcinoma of the ovary diagnosed with short tandem repeat analysis: case report and review of the literature</article-title>
          <source>Int J Gynecol Cancer</source>
          <year>2007</year>
          <volume>17</volume>
          <issue>1</issue>
          <fpage>254</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">17291262</pub-id>
        </element-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsujioka</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hamada</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Miyakawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hachissuga</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kawarabayashi</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>A pure nongestational choriocarcinoma of the ovary diagnosed with DNA polymorphism analysis</article-title>
          <source>Gynecol Oncol</source>
          <year>2003</year>
          <volume>89</volume>
          <issue>3</issue>
          <fpage>540</fpage>
          <lpage>2</lpage>
          <pub-id pub-id-type="pmid">12798727</pub-id>
        </element-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lorigan</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Colman</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Hancock</surname>
              <given-names>BW</given-names>
            </name>
          </person-group>
          <article-title>The treatments of persistent trophoblastic disease using the Sheffield modification of chaing cross risk score</article-title>
          <source>Proc Annu Meeting Am Soc Clin Oncol</source>
          <year>1994</year>
          <volume>13</volume>
          <fpage>257</fpage>
        </element-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lorigan</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Grierson</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Goepel</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Coleman</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Goyns</surname>
              <given-names>MH</given-names>
            </name>
          </person-group>
          <article-title>Gestational choriocarcinoma of the ovary diagnosed by analysis of tumor DNA</article-title>
          <source>Cancer Letter</source>
          <year>1996</year>
          <volume>104</volume>
          <issue>1</issue>
          <fpage>27</fpage>
          <lpage>30</lpage>
        </element-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <element-citation publication-type="journal">
          <article-title>Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 15-1977</article-title>
          <source>N Engl J Med</source>
          <year>1977</year>
          <volume>296</volume>
          <issue>15</issue>
          <fpage>865</fpage>
          <lpage>73</lpage>
          <pub-id pub-id-type="pmid">191750</pub-id>
        </element-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Russell</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Farnsworth</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Surgical pathology of the ovaries</article-title>
          <year>1997</year>
          <edition>2nd sub ed</edition>
          <publisher-loc>Philadelphia</publisher-loc>
          <publisher-name>W.B. Saunders Company</publisher-name>
          <fpage>785</fpage>
          <lpage>7</lpage>
        </element-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gerbie</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Brewer</surname>
              <given-names>JI</given-names>
            </name>
            <name>
              <surname>Tamimi</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Primary choriocarcinoma of the ovary</article-title>
          <source>Obstet Gynecol</source>
          <year>1975</year>
          <volume>46</volume>
          <issue>6</issue>
          <fpage>720</fpage>
          <lpage>3</lpage>
          <pub-id pub-id-type="pmid">1237831</pub-id>
        </element-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaneta</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yoshiyama</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Inagaki</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Toyoshima</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nishino</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Gestational choriocarcinoma whose responsible pregnancy was a complete hydatidiform mole identified by PCR analysis with new sequence tagged site primers</article-title>
          <source>Jpn J Clin Oncol</source>
          <year>1999</year>
          <volume>29</volume>
          <issue>10</issue>
          <fpage>504</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">10645807</pub-id>
        </element-citation>
      </ref>
      <ref id="ref11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vance</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Geisinger</surname>
              <given-names>KR</given-names>
            </name>
          </person-group>
          <article-title>Pure nongestational choriocarcinoma of the ovary report of a case</article-title>
          <source>Cancer</source>
          <year>1985</year>
          <volume>56</volume>
          <issue>9</issue>
          <fpage>2321</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">3902208</pub-id>
        </element-citation>
      </ref>
      <ref id="ref12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Axe</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>VR</given-names>
            </name>
            <name>
              <surname>Woodruff</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>Choriocarcinoma of the ovary</article-title>
          <source>Obstet Gynecol</source>
          <year>1985</year>
          <volume>66</volume>
          <issue>1</issue>
          <fpage>111</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="pmid">4040229</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
